...
首页> 外文期刊>European journal of pharmaceutical sciences >Development of solid SEDDS, VI: Effect of precoating of Neusilin ? US2 with PVP on drug release from adsorbed self-emulsifying lipid-based formulations
【24h】

Development of solid SEDDS, VI: Effect of precoating of Neusilin ? US2 with PVP on drug release from adsorbed self-emulsifying lipid-based formulations

机译:发展实心潜水,VI:牙本菌素灌注的效果吗? US2具有PVP对吸附自乳化脂质的制剂的药物释放

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Adsorption of lipid-based formulations, which are usually liquid, onto silicas has been extensively investigated in the past decade to convert them into solid dosage forms. There are conflicting reports on the ability of commercially available porous silicas, like Neusilin ? US2, to release lipid formulations completely, especially after long-term storage. In this study, the release of a model drug, probucol, from different formulations of medium chain lipids and a surfactant, Kolliphor EL (Cremophor EL) or polysorbate 80, were studied after adsorbing them onto Neusilin ? US2. Complete drug release (>80%) was obtained from all formulations on Day 1; however, the extent of drug release decreased progressively with time. The decrease was dependent on the relative hydrophilicity of the formulations. The maximum decrease ( ? US2 with polyvinylpyrrolidone (PVP), by treating the silicate with an alcoholic solution of PVP and then drying, eliminated or minimized the decrease in drug release upon storage, possibly by blocking the mesoporous region of the silicate and improving hydration and allowing emulsification of the formulations within the larger pores. Formulations containing PVP K-90 precoated on Neusilin ? US2 exhibited complete drug release (>80%) even after 6months of storage. Graphical abstract Display Omitted
机译:摘要在过去十年中,广泛研究了脂质基制剂,其通常是液体,其在二十年中被广泛研究了它们以固体剂型转化为固体剂型。有关市售多孔三硅的能力存在矛盾的报道,如neusilin? US2,完全释放脂质制剂,特别是在长期储存之后。在本研究中,在将它们吸附到Neusilin之后,研究了模型药物,来自中链脂质和表面活性剂,kolliphor el(Cremophor EL)或聚山梨醇酯80的不同配方的释放。 US2。完全药物释放(> 80%)是从第1天的所有制剂中获得的;然而,药物释放程度随时间逐渐减少。减少依赖于制剂的相对亲水性。通过将硅酸盐与PVP的酒精溶液用含酒精溶液处理,消除或最小化储存时,通过阻断硅酸盐和改善水合的介孔区域,通过阻止硅酸盐,消除或最小化药物释放的降低,最大降低(αu2,通过聚乙烯吡咯烷酮(PVP)。允许在较大孔内乳化制剂。即使在储存6个月后,含有PVP K-90的配方均表现出完全药物释放(> 80%)。省略了图形抽象显示

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号